Securities Code: 300298
Securities Abbreviation: Sanor Biotech
Announcement Number: 2026-069
Bond Code: 123090
Bond Abbreviation: Sanor Convertible Bond
Sanor Biotech Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
The Company held the 14th meeting of the 4th Board of Directors on April 15, 2021, and the 2020 Annual General Meeting on May 10, 2021, to review and approve the proposal on the "Second Employee Stock Ownership Plan (Draft)" and its summary, as well as the proposal to authorize the Board of Directors to handle matters related to the second employee stock ownership plan. The Board of Directors was authorized to handle specific matters related to the second employee stock ownership plan.
On May 26, 2021, the Company held the 15th meeting of the 4th Board of Directors, reviewing and approving the proposal on the "Second Employee Stock Ownership Plan (Revised Draft)" and its summary, as well as the proposal on the "Management Measures for the Second Employee Stock Ownership Plan (Revised Draft)." The Company agreed to revise certain contents of the "Second Employee Stock Ownership Plan (Draft)" and "Management Measures for the Second Employee Stock Ownership Plan" in accordance with the Company Law, Securities Law, relevant laws, administrative regulations, normative documents, and the Company's Articles of Association, combined with the actual situation of the Company.
On April 27, 2026, the Company held the 4th meeting of the 6th Board of Directors, and on May 26, 2026, the 2025 Annual General Meeting, to review and approve the proposal on the "Second Employee Stock Ownership Plan (Second Revised Draft)" and its summary, the proposal on the "Management Measures for the Second Employee Stock Ownership Plan (Second Revised Draft)," and the proposal to authorize the Board of Directors to handle matters related to the second employee stock ownership plan. The Company agreed to revise and improve matters related to the scope of plan participants, management model, handling of participant rights, unlocking, and assessment arrangements. For specific details, please refer to the relevant announcements disclosed by the Company on the Giant Tide Information Network (www.cninfo.com.cn).